Citations (126)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Bruce A. Mungall, Bernard Hoet, Javier Nieto Guevara & Lamine Soumahoro. (2022) A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Review of Vaccines 21:2, pages 201-214.
Read now
Read now
Patricia Izurieta & Javier Nieto Guevara. (2022) Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Lindsay R. Grant, Mary P. E. Slack, Qi Yan, Krzysztof Trzciński, Jane Barratt, Elizabeth Sobczyk, James Appleby, Alejandro Cané, Luis Jodar, Raul E. Isturiz & Bradford D. Gessner. (2021) The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy. Expert Review of Vaccines 20:6, pages 691-705.
Read now
Read now
A. W. Dretler, N. G. Rouphael & D. S. Stephens. (2018) Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Human Vaccines & Immunotherapeutics 14:5, pages 1146-1160.
Read now
Read now
Volker Vetter, Gülhan Denizer, Leonard R. Friedland, Jyothsna Krishnan & Marla Shapiro. (2018) Understanding modern-day vaccines: what you need to know. Annals of Medicine 50:2, pages 110-120.
Read now
Read now
Jane N Zuckerman, Christoph Hatz & Anu Kantele. (2017) Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines. Expert Review of Vaccines 16:10, pages 1029-1043.
Read now
Read now
Xiaomei Hu, Zhijin Chen, Kun Xiong, Jing Wang, Xiancai Rao & Yanguang Cong. (2017) Vi capsular polysaccharide: Synthesis, virulence, and application. Critical Reviews in Microbiology 43:4, pages 440-452.
Read now
Read now
Ed Clarke, Beate Kampmann & David Goldblatt. (2016) Maternal and neonatal pneumococcal vaccination - where are we now?. Expert Review of Vaccines 15:10, pages 1305-1317.
Read now
Read now
Ghassan Dbaibo, Vladimir Tatochenko & Peter Wutzler. (2016) Issues in pediatric vaccine-preventable diseases in low- to middle-income countries. Human Vaccines & Immunotherapeutics 12:9, pages 2365-2377.
Read now
Read now
Beatriz P. Quiambao, Hermant Jain, Ashish Bavdekar, Anand Prakash Dubey, Devayani Kolhe, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2016) Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents. Human Vaccines & Immunotherapeutics 12:8, pages 2162-2168.
Read now
Read now
Calman A MacLennan, Laura B Martin & Francesca Micoli. (2014) Vaccines against invasive Salmonella disease. Human Vaccines & Immunotherapeutics 10:6, pages 1478-1493.
Read now
Read now
Yorgo C Zahlanie, Moza M Hammadi, Soha T Ghanem & Ghassan S Dbaibo. (2014) Review of meningococcal vaccines with updates on immunization in adults. Human Vaccines & Immunotherapeutics 10:4, pages 995-1007.
Read now
Read now
Carine P Hedari, Rima W Khinkarly & Ghassan S Dbaibo. (2014) Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infection and Drug Resistance 7, pages 85-99.
Read now
Read now
Catherine Cordonnier, Diana Averbuch, Sébastien Maury & Dan Engelhard. (2014) Pneumococcal immunization in immunocompromised hosts: where do we stand?. Expert Review of Vaccines 13:1, pages 59-74.
Read now
Read now
Daniel Novak, Anna Lundgren, Susanne Westphal, Sindri Valdimarsson, Martin L. Olsson & Birger Trollfors. (2013) Two cases of hemolytic uremic syndrome caused by Streptococcus pneumoniae serotype 3, one being a vaccine failure. Scandinavian Journal of Infectious Diseases 45:5, pages 411-414.
Read now
Read now
Muhamed-Kheir Taha & Ala-Eddine Deghmane. (2012) New recombinant vaccines for the prevention of meningococcal B disease. Vaccine: Development and Therapy 2, pages 15-22.
Read now
Read now
Ghassan Dbaibo, Noel Macalalad, Mari Rose Aplasca-De Los Reyes, Efren Dimaano, Véronique Bianco, Yaela Baine & Jacqueline M. Miller. (2012) The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine. Human Vaccines & Immunotherapeutics 8:7, pages 873-880.
Read now
Read now
Michael Bröker, Brian Cooper, Lisa M DeTora & Jeffrey J Stoddard. (2011) Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease. Infection and Drug Resistance 4, pages 137-147.
Read now
Read now
Articles from other publishers (108)
Siti Aisyah Razali, Mohd Shahir Shamsir, Nur Farahin Ishak, Chen-Fei Low & Wan-Atirah Azemin. (2023) Riding the wave of innovation: immunoinformatics in fish disease control. PeerJ 11, pages e16419.
Crossref
Crossref
Djamel Nehar-Belaid, Mark Sokolowski, Sathyabaarathi Ravichandran, Jacques Banchereau, Damien Chaussabel & Duygu Ucar. (2023) Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS. Seminars in Immunology 70, pages 101842.
Crossref
Crossref
Carlos E. Rivera, Yulai Zhou, Daniel P. Chupp, Hui YanAmanda D. Fisher, Raphael SimonHong Zan, Zhenming Xu & Paolo Casali. (2023) Intrinsic B cell TLR-BCR linked coengagement induces class-switched, hypermutated, neutralizing antibody responses in absence of T cells. Science Advances 9:17.
Crossref
Crossref
Artur Kibler, Marc Seifert & Bettina Budeus. (2023) Age-related changes of the human splenic marginal zone B cell compartment. Immunology Letters.
Crossref
Crossref
Francesca Micoli, Maria Rosaria Romano, Filippo Carboni, Roberto Adamo & Francesco Berti. (2023) Strengths and weaknesses of pneumococcal conjugate vaccines. Glycoconjugate Journal 40:2, pages 135-148.
Crossref
Crossref
Santiago M.C. Lopez, Alice I. Sato & Archana Chatterjee. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
699
717
.
Claire-Anne Siegrist & Christiane S. Eberhardt. 2023. Plotkin's Vaccines. Plotkin's Vaccines
17
36.e7
.
Saiprasad Narsingam, Jeffrey Munson & Frank Drescher. (2022) Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans. Vaccine 40:35, pages 5223-5228.
Crossref
Crossref
Yoshikazu Honda-Okubo, Robert T. Cartee, Ann Thanawastien, Jae Seung Yang, Kevin P. Killeen & Nikolai Petrovsky. (2022) A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates. Vaccine 40:32, pages 4625-4634.
Crossref
Crossref
Francesca Rech, Riccardo De Ricco, Sara Giannini, Luca Nompari, Marilena Paludi, Stefania Berti, Chiara Parlati, Simona Cianetti & Francesco Berti. (2022) Glycoconjugate content quantification to assess vaccine potency: A simplified approach. Biologicals 76, pages 10-14.
Crossref
Crossref
Arun B. Arunachalam, Stacey Vile & Angel Rosas. (2022) A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines. Frontiers in Immunology 13.
Crossref
Crossref
Abhijeet Nayak. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics
163
200
.
Chakkumkal Anish, Michel Beurret & Jan Poolman. (2021) Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines. npj Vaccines 6:1.
Crossref
Crossref
Wook-Jin Park, Yeon-Kyung Yoon, Ji-Sun Park, Ruchirkumar Pansuriya, Yeong-Jae Seok & Ravi Ganapathy. (2021) Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine. Scientific Reports 11:1.
Crossref
Crossref
M. Ariel Spurrier, Jamie E. Jennings-Gee, Christina A. Daly & Karen M. Haas. (2021) The PD-1 Regulatory Axis Inhibits T Cell–Independent B Cell Memory Generation and Reactivation. The Journal of Immunology 207:8, pages 1978-1989.
Crossref
Crossref
Nadezhda Wall, Alexandra Godlee, Daniel Geh, Charlotte Jones, Sian Faustini, Ruth Harvey, Rebecca Penn, Dimitrios Chanouzas, Peter Nightingale, Matthew O’Shea, Alex Richter, Paul Moss, Adam Cunningham & Lorraine Harper. (2021) Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease. Clinical Infectious Diseases 73:4, pages e880-e889.
Crossref
Crossref
R.K. Lucinde, G. Ong'ayo, C. Houlihan, C. Bottomley, D Goldblatt, J.A.G. Scott & K.E. Gallagher. (2021) Pneumococcal conjugate vaccine dose-ranging studies in humans: A systematic review. Vaccine 39:36, pages 5095-5105.
Crossref
Crossref
Ailsa Robbins, Mathilde Bahuaud, Maxime Hentzien, Quentin Maestraggi, Coralie Barbe, Delphine Giusti, Richard Le Naour, Frederic Batteux & Amélie Servettaz. (2021) The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency. Frontiers in Immunology 12.
Crossref
Crossref
M. V. Abramtseva, E. O. Nemanova, N. S. Alekhina & T. I. Nemirovskaya. (2021) Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products. BIOpreparations. Prevention, Diagnosis, Treatment 21:2, pages 85-96.
Crossref
Crossref
Abelardo Fernández Chávez, Luis García Comas, Juan Carlos Sanz Moreno, Rafael Cantón Moreno, Octavio Corral Pazos de Provens & Jesús María Aranaz Andrés. (2021) Effect of childhood pneumococcal vaccination and beta-lactam antibiotic use on the incidence of invasive pneumococcal disease in the adult population. European Journal of Clinical Microbiology & Infectious Diseases 40:7, pages 1529-1538.
Crossref
Crossref
Claire Froneman, Peter Kelleher & Ricardo J. José. (2021) Pneumococcal Vaccination in Immunocompromised Hosts: An Update. Vaccines 9:6, pages 536.
Crossref
Crossref
Cristina Masuet-Aumatell & Jorge Atouguia. (2021) Typhoid fever infection – Antibiotic resistance and vaccination strategies: A narrative review. Travel Medicine and Infectious Disease 40, pages 101946.
Crossref
Crossref
Muhamed-Kheir Taha, Jessica Presa & Lidia Serra. (2021) A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa. International Journal of Infectious Diseases 104, pages 189-197.
Crossref
Crossref
Ala-Eddine Deghmane & Muhamed-Kheir Taha. (2021) Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review. Microorganisms 9:3, pages 467.
Crossref
Crossref
Canna Jagdish Ghia & Gautam Sudhakar Rambhad. (2021) Meningococcal Disease Burden in India: A Systematic Review and Meta-Analysis. Microbiology Insights 14, pages 117863612110533.
Crossref
Crossref
Chiara Azzari & Clementina Canessa. 2021. Cellular Primary Immunodeficiencies. Cellular Primary Immunodeficiencies
455
471
.
Joseph Domachowske. 2021. Vaccines. Vaccines
3
11
.
Christina A. Daly, M. Ariel Spurrier, Jamie E. Jennings-Gee & Karen M. Haas. (2020) B Cell Subsets Differentially Contribute to the T Cell–Independent Memory Pool. The Journal of Immunology 205:9, pages 2362-2374.
Crossref
Crossref
Francesca MicoliStefania P. Bjarnarson, Melissa ArcuriAudur Anna Aradottir PindGudbjorg J. MagnusdottirFrancesca NecchiRoberta Di BenedettoMartina Carducci, Fabiola SchiavoCarlo Giannelli, Ivan PisoniLaura B. MartinGiuseppe Del GiudiceCalman A. MacLennanRino Rappuoli, Ingileif JonsdottirAllan Saul. (2020)
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM
197
conjugate vaccine
. Proceedings of the National Academy of Sciences 117:39, pages 24443-24449.
Crossref
Crossref
Jairam Meena, Robin Kumar, Mamta Singh, Anees Ahmed & Amulya Kumar Panda. (2020) Modulation of immune response and enhanced clearance of Salmonella typhi by delivery of Vi polysaccharide conjugate using PLA nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 152, pages 270-281.
Crossref
Crossref
Rotem Lapidot, Kimberly Shea, Inci Yildirim, Howard Cabral, Stephen Pelton & the Massachusetts Department of Public Health. (2020) Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts. Pathogens 9:5, pages 396.
Crossref
Crossref
Ayesha Khan, Femke Hollwedel, Ulrich A. Maus, Bridget L. Stocker & Mattie S.M. Timmer. (2020) Synthesis of α-Glucosyl Diacylglycerides as potential adjuvants for Streptococcus pneumoniae vaccines. Carbohydrate Research 489, pages 107951.
Crossref
Crossref
Bertolini Daniela Vinhas, Costa Luciana Scarlazzari, de Castro Bruno Stuart, Pernichelli Tadeu, van der Heijden Inneke Marie, Costa Silvia Figueiredo, Sato Helena Keiko & de Sousa Marques Heloisa Helena. (2020) Validity of Enzyme-Linked Immunosorbent Assay (ELISA) as a correlate of protection of meningococcal C conjugated vaccine in adolescents with HIV infection. Journal of Vaccines and Immunology 6:1, pages 001-007.
Crossref
Crossref
Xi Zen Yap, Matthew B. B. McCall & Robert W. Sauerwein. (2019)
Fast and fierce versus slow and smooth: Heterogeneity in immune responses to
Plasmodium
in the controlled human malaria infection model
. Immunological Reviews 293:1, pages 253-269.
Crossref
Crossref
Francisco A. Bonilla. 2020. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
1157
1173
.
Esther de Vries & Ger T. Rijkers. 2020. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
537
542
.
Mark van der Linden, Matthias Imöhl & Stephanie Perniciaro. (2019) Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLOS ONE 14:8, pages e0220453.
Crossref
Crossref
Francesca Mantile, Angelo Capasso, Piergiuseppe De Berardinis & Antonella Prisco. (2019) Identification of a Consolidation Phase in Immunological Memory. Frontiers in Immunology 10.
Crossref
Crossref
Paul V Licciardi, Eng Lee Tan, Peng Li & Oon Tek Ng. (2018) Pneumococcal vaccination for HIV-infected individuals in Singapore. Proceedings of Singapore Healthcare 28:1, pages 55-60.
Crossref
Crossref
Anita van den Biggelaar, William Pomat, Geraldine Masiria, Sandra Wana, Birunu Nivio, Jacinta Francis, Rebecca Ford, Megan Passey, Lea-Ann Kirkham, Peter Jacoby, Deborah Lehmann & Peter Richmond. (2019) Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children. Vaccines 7:1, pages 17.
Crossref
Crossref
James P Phipps & Karen M Haas. (2019) An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses. The Journal of Infectious Diseases 219:2, pages 323-334.
Crossref
Crossref
Ezra Linley, Abigail Bell, Jenna F. Gritzfeld & Ray Borrow. (2019) Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?. Vaccines 7:1, pages 4.
Crossref
Crossref
E G J von Asmuth, H J Brockhoff, J Wallinga & L G Visser. (2019)
S. typhi
Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease
. Journal of Travel Medicine 26:1.
Crossref
Crossref
Annefleur C. Langedijk, Mariëlle van Aalst, Bob Meek, Ester M.M. van Leeuwen, Sacha Zeerleder, Ellen Meijer, Mette D. Hazenberg, Martin P. Grobusch & Abraham Goorhuis. (2019) Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation. Vaccine 37:3, pages 510-515.
Crossref
Crossref
Joseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine GibneyJoseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine Gibney. 2019. Manual of Travel Medicine. Manual of Travel Medicine
19
169
.
Godwin Oligbu, Norman K. Fry & Shamez N. Ladhani. 2019. Streptococcus pneumoniae. Streptococcus pneumoniae
215
224
.
Nils Littorin, Fabian Uddén, Jonas Ahl, Fredrik Resman, Hans-Christian Slotved, Simon Athlin & Kristian Riesbeck. (2018) Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease. Frontiers in Microbiology 9.
Crossref
Crossref
C Ferlito, R Biselli, M S Cattaruzza, R Teloni, S Mariotti, E Tomao, G Salerno, M S Peragallo, P Lulli, S Caporuscio, A Autore, G Bizzarro, V Germano, M I Biondo, A Picchianti Diamanti, S Salemi, R Nisini & R D'Amelio. (2018) Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults. Clinical and Experimental Immunology 194:3, pages 361-370.
Crossref
Crossref
Matthew B.B. McCall, Peter G. Kremsner & Benjamin Mordmüller. (2018) Correlating efficacy and immunogenicity in malaria vaccine trials. Seminars in Immunology 39, pages 52-64.
Crossref
Crossref
Cinzia Colombo, Olimpia Pitirollo & Luigi Lay. (2018) Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development. Molecules 23:7, pages 1712.
Crossref
Crossref
Paraskevi F Farmaki, Maria C Chini, Nikolaos M Mangafas, Marianna T Tzanoudaki, Christina P Piperi, Marios Z Lazanas & Vana S Spoulou. (2018) Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults. The Journal of Infectious Diseases 218:1, pages 26-34.
Crossref
Crossref
Baldassarre Martire, Chiara Azzari, Raffaele Badolato, Clementina Canessa, Emilia Cirillo, Vera Gallo, Simona Graziani, Tiziana Lorenzini, Cinzia Milito, Raffaella Panza & Viviana Moschese. (2018) Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET). Vaccine 36:24, pages 3541-3554.
Crossref
Crossref
Lisa A. Jackson, Hana M. El Sahly, Sarah George, Patricia Winokur, Kathryn Edwards, Rebecca C. Brady, Nadine Rouphael, Wendy A. Keitel, Mark J. Mulligan, Robert L. Burton, Aya Nakamura, Jennifer Ferreria & Moon H. Nahm. (2018) Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 36:5, pages 606-614.
Crossref
Crossref
Claire-Anne Siegrist. 2018. Plotkin's Vaccines. Plotkin's Vaccines
16
34.e7
.
Daniel O’Connor, Elizabeth A. Clutterbuck, Amber J. Thompson, Matthew D. Snape, Maheshi N. Ramasamy, Dominic F. Kelly & Andrew J. Pollard. (2017) High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Medicine 9:1.
Crossref
Crossref
Anita H. J. van den Biggelaar, Peter C. Richmond, Angela Fuery, Denise Anderson, Christine Opa, Gerard Saleu, Mildred Lai, Jacinta P. Francis, Michael P. Alpers, William S. Pomat & Deborah Lehmann. (2017) Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination. PLOS ONE 12:10, pages e0185877.
Crossref
Crossref
Paul V Licciardi, Edwin Hoe, Zheng Quan Toh, Anne Balloch, Sarah Moberley, Paula Binks, Rachel Marimla, Amanda Leach, Sue Skull, Kim Mulholland & Ross Andrews. (2017) Repeat pneumococcal polysaccharide vaccination does not impair functional immune responses among Indigenous Australians. Clinical & Translational Immunology 6:10, pages e158.
Crossref
Crossref
S. H. Pakkanen, J. M. Kantele, L. Rombo & A. Kantele. (2017) Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine. Scandinavian Journal of Immunology 86:4, pages 207-215.
Crossref
Crossref
Sabelle Jallow, Shabir A. Madhi, Richard Madimabe, Nosisa Sipambo, Avy Violari, Udai Kala, Karen Petersen, Sanushka Naidoo, Charl Verwey, David P. Moore & Marta C. Nunes. (2017) Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions. Vaccine 35:34, pages 4321-4329.
Crossref
Crossref
Tim Niehues, Christian Bogdan, Jane Hecht, Thomas Mertens, Miriam Wiese-Posselt & Fred Zepp. (2017) Impfen bei Immundefizienz. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 60:6, pages 674-684.
Crossref
Crossref
Heidi Schaballie, Barbara Bosch, Rik Schrijvers, Marijke Proesmans, Kris De Boeck, Mieke Nelly Boon, François Vermeulen, Natalie Lorent, Doreen Dillaerts, Glynis Frans, Leen Moens, Inge Derdelinckx, Willy Peetermans, Bjørn Kantsø, Charlotte Svaerke Jørgensen, Marie-Paule Emonds, Xavier Bossuyt & Isabelle Meyts. (2017) Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide Response. Frontiers in Immunology 8.
Crossref
Crossref
Lina Pérez-Breva, Raquel Abad-Torreblanca, Miguel Ángel Martínez-Beneito, Joan Puig-Barberà, Sara Alemán-Sánchez, Nuria Morant-Talamante, Macrina Sastre-Cantón, Julio A. Vázquez-Moreno & Javier Díez-Domingo. (2017) Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination. Vaccine 35:22, pages 2949-2954.
Crossref
Crossref
Johannes Trück, Amber Thompson, Begonia Morales-Aza, Elizabeth A. Clutterbuck, Merryn Voysey, Ed Clarke, Matthew D. Snape, Dominic F. Kelly, Adam Finn & Andrew J. Pollard. (2017) Memory B cell response to a PCV-13 booster in 3.5 year old children primed with either PCV-7 or PCV-13. Vaccine 35:20, pages 2701-2708.
Crossref
Crossref
Djursun Karasartova, Umut Gazi, Ozgur Tosun, Ayse S. Gureser, Ibrahim T. Sahiner, Mete Dolapci & Aysegul T. Ozkan. (2017) Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals. Journal of Clinical Immunology 37:4, pages 388-396.
Crossref
Crossref
Nils Littorin, Jonas Ahl, Fabian Uddén, Fredrik Resman & Kristian Riesbeck. (2016) Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county. BMC Infectious Diseases 16:1.
Crossref
Crossref
Calman A. MacLennan, Alex Richter, James Hodson, Sian Faustini, Jane Birtwistle, Alison Whitelegg, Joyful Chigiga, Mebie Singo, Jodie Walker-Haywood, Betselot Mulugeta, Sindiso Masuka, Chris Mainey, Tim Plant, Mark T. Drayson & Kaveh Manavi. (2016) Brief Report: Immunization of HIV-Infected Adults in the UK With Haemophilus influenzae b/Meningococcal C Glycoconjugate and Pneumococcal Polysaccharide Vaccines. JAIDS Journal of Acquired Immune Deficiency Syndromes 73:3, pages 287-293.
Crossref
Crossref
Germie P.J.M. van den Dobbelsteen, Kellen C. Faé, Jan Serroyen, Ingrid M. van den Nieuwenhof, Martin Braun, Micha A. Haeuptle, Dominique Sirena, Joerg Schneider, Cristina Alaimo, Gerd Lipowsky, Veronica Gambillara-Fonck, Michael Wacker & Jan T. Poolman. (2016) Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models. Vaccine 34:35, pages 4152-4160.
Crossref
Crossref
Paul V. Licciardi, Zheng Quan Toh, Elizabeth A. Clutterbuck, Anne Balloch, Rachel A. Marimla, Leena Tikkanen, Karen E. Lamb, Kathryn J. Bright, Uraia Rabuatoka, Lisi Tikoduadua, Laura K. Boelsen, Eileen M. Dunne, Catherine Satzke, Yin Bun Cheung, Andrew J. Pollard, Fiona M. Russell & Edward K. Mulholland. (2016) No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine. Journal of Allergy and Clinical Immunology 137:6, pages 1772-1779.e11.
Crossref
Crossref
Ioanna Papadatou & Vana Spoulou. (2016) Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?. Clinical and Vaccine Immunology 23:5, pages 388-395.
Crossref
Crossref
Francisco Sanz-Herrero, Concepción Gimeno-Cardona, Nuria Tormo-Palop, Estrella Fernández-Fabrellas, María Luisa Briones, Ángela Cervera-Juan & José Blanquer-Olivas. (2016) The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia. Vaccine 34:15, pages 1847-1852.
Crossref
Crossref
Christopher R. Doyle & Liise-anne Pirofski. (2016) Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody. mBio 7:1.
Crossref
Crossref
Prakhar Vijayvargiya, Diana Marian, Maria T. Vazquez-Pertejo & Larry M. Bush. (2016) Unwarranted Pneumococcal Vaccination in an Acute Care Hospital Related to Core Quality Measure Initiatives. Infectious Diseases in Clinical Practice 24:1, pages 24-28.
Crossref
Crossref
Brian A. Kendall, Kristin K. Dascomb, Rajesh R. Mehta, Chris Stockmann, Edward O. Mason, Krow Ampofo, Andrew T. Pavia & Carrie L. Byington. (2016) Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine 34:4, pages 474-478.
Crossref
Crossref
Vibe C Ballegaard, Lone Schejbel, Steen Hoffmann, Bjørn Kantsø & Christian P Fischer. (2015) Recurrent severe invasive pneumococcal disease in an adult with previously unknown hyposplenia. BMC Infectious Diseases 15:1.
Crossref
Crossref
Karen M. Haas. (2015) B-1 lymphocytes in mice and nonhuman primates. Annals of the New York Academy of Sciences 1362:1, pages 98-109.
Crossref
Crossref
Vadrevu Krishna Mohan, Vineeth Varanasi, Anit Singh, Marcela F. Pasetti, Myron M. Levine, Ramasamy Venkatesan & Krishna M. Ella. (2015) Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study. Clinical Infectious Diseases 61:3, pages 393-402.
Crossref
Crossref
Louise Roggelin, Christof D. Vinnemeier, Johanna Fischer-Herr, Brandi T. Johnson-Weaver, Thierry Rolling, Gerd D. Burchard, Herman F. Staats & Jakob P. Cramer. (2015) Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers. Vaccine 33:33, pages 4141-4145.
Crossref
Crossref
I. Papadatou, G. Orthopoulos, M. Theodoridou & V. Spoulou. (2015) Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic patients with β-thalassemia major. Vaccine 33:32, pages 3779-3783.
Crossref
Crossref
Anu Goenka & Tobias R. Kollmann. (2015) Development of immunity in early life. Journal of Infection 71, pages S112-S120.
Crossref
Crossref
H Schaballie, F Vermeulen, B Verbinnen, G Frans, E Vermeulen, M Proesmans, K De Vreese, M P Emonds, K De Boeck, L Moens, C Picard, X Bossuyt & I Meyts. (2015) Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency. Clinical and Experimental Immunology 180:2, pages 271-279.
Crossref
Crossref
B. Wyplosz, O. Derradji, E. Hong, H. François, A. Durrbach, J.-C. Duclos-Vallée, D. Samuel, L. Escaut, O. Launay, D. Vittecoq & M.K. Taha. (2015) Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients. Transplant Infectious Disease 17:2, pages 322-327.
Crossref
Crossref
B.M. Hauptmeier & G.G.U. Rohde. (2015) Impfungen zur PneumonieprophylaxeVaccinations for pneumonia prophylaxis. Der Pneumologe 12:2, pages 110-117.
Crossref
Crossref
Neil Ravenscroft, Paolo Costantino, Philippe Talaga, Roberto Rodriguez & William Egan. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control
301
381
.
Helen Petousis-Harris. 2015. The Practical Compendium of Immunisations for International Travel. The Practical Compendium of Immunisations for International Travel
3
12
.
C. Forstner & M.W. Pletz. (2014) PneumokokkenimpfungPneumococcal vaccination. Der Pneumologe 11:6, pages 506-515.
Crossref
Crossref
I. Papadatou, C. Piperi, K. Alexandraki, A. Kattamis, M. Theodoridou & V. Spoulou. (2014) Antigen-Specific B-Cell Response to 13-Valent Pneumococcal Conjugate Vaccine in Asplenic Individuals With -Thalassemia Previously Immunized With 23-Valent Pneumococcal Polysaccharide Vaccine. Clinical Infectious Diseases 59:6, pages 862-865.
Crossref
Crossref
Mohamed Khalil, Yagob Al-Mazrou, Helen Findlow, Helen Chadha, Valerie Bosch Castells, Philipp Oster & Ray Borrow. (2014) Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine. Vaccine 32:43, pages 5715-5721.
Crossref
Crossref
Chakkumkal Anish, Benjamin Schumann, Claney Lebev Pereira & Peter H. Seeberger. (2014) Chemical Biology Approaches to Designing Defined Carbohydrate Vaccines. Chemistry & Biology 21:1, pages 38-50.
Crossref
Crossref
Francisco A. Bonilla. 2014. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
989
1005
.
Belkis Romeu, Miriam Lastre, Luis García, Bárbara Cedré, Aleida Mandariote, Mildrey Fariñas, Reynaldo Oliva & Oliver Pérez. (2013) Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A. Immunologic Research 58:1, pages 75-85.
Crossref
Crossref
Diana C. Otczyk & Allan W. Cripps. (2016) Vaccination for the control of childhood bacterial pneumonia — Haemophilus influenzae type b and pneumococcal vaccines. Pneumonia 2:1, pages 2-15.
Crossref
Crossref
Jonas Ahl, Nils Littorin, Arne Forsgren, Inga Odenholt, Fredrik Resman & Kristian Riesbeck. (2013) High incidence of septic shock caused by Streptococcus pneumoniae serotype 3 - a retrospective epidemiological study. BMC Infectious Diseases 13:1.
Crossref
Crossref
A. Krause & K. Krüger. (2013) Pneumokokkenimpfung bei immunsupprimierten PatientenPneumococcus vaccination in immunosuppressed patients. Zeitschrift für Rheumatologie 72:10, pages 942-946.
Crossref
Crossref
Francesca Micoli, Maria Rosaria RomanoMarta TontiniEmilia Cappelletti, Massimiliano Gavini, Daniela ProiettiSimona Rondini, Erwin SwennenLaura SantiniSara FilippiniCristiana BalocchiRoberto AdamoGerd PluschkeGunnstein Norheim, Andrew PollardAllan Saul, Rino RappuoliCalman A. MacLennan, Francesco BertiPaolo Costantino. (2013) Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proceedings of the National Academy of Sciences 110:47, pages 19077-19082.
Crossref
Crossref
F. Speth, N. Wellinghausen & J.-P. Haas. (2013) Medikamentöse Prophylaxe während intensivierter Immunsuppression bei Kindern und JugendlichenMedicinal prophylaxis during intensified immunosuppression in children and adolescents. Zeitschrift für Rheumatologie 72:9, pages 896-909.
Crossref
Crossref
Stefania P. Bjarnarson, Hreinn Benonisson, Giuseppe Del Giudice & Ingileif Jonsdottir. (2013) Pneumococcal Polysaccharide Abrogates Conjugate-Induced Germinal Center Reaction and Depletes Antibody Secreting Cell Pool, Causing Hyporesponsiveness. PLoS ONE 8:9, pages e72588.
Crossref
Crossref
Alastair C. McGregor, Claire S. Waddington & Andrew J. Pollard. (2013) Prospects for prevention of Salmonella infection in children through vaccination. Current Opinion in Infectious Diseases 26:3, pages 254-262.
Crossref
Crossref
Ghassan Dbaibo, Nabil El-Ayoubi, Soha Ghanem, Farah Hajar, Veronique Bianco, Jacqueline M. Miller & Narcisa Mesaros. (2013) Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial. Drugs & Aging 30:5, pages 309-319.
Crossref
Crossref
Martina Prelog. (2013) Differential Approaches for Vaccination from Childhood to Old Age. Gerontology 59:3, pages 230-239.
Crossref
Crossref
Lara Danziger‐Isakov & Klara M. Posfay‐Barbe. (2012) Optimal approach to immunization in pediatric solid organ transplantation. Pediatric Transplantation 16:7, pages 680-683.
Crossref
Crossref
Janoi Chang, Yohanna Serrano, Raine Garrido, Laura M. Rodríguez, Jessy Pedroso, Felix Cardoso, Yury Valdés, Dagmar García, Violeta Fernández-Santana & Vicente Verez-Bencomo. (2012) Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide. Vaccine 30:49, pages 7090-7096.
Crossref
Crossref
Chakkumkal Anish, Dinesh G. Goswami, Vibhu Kanchan, Simi Mathew & Amulya K. Panda. (2012) The immunogenic characteristics associated with multivalent display of Vi polysaccharide antigen using biodegradable polymer particles. Biomaterials 33:28, pages 6843-6857.
Crossref
Crossref
Ray Borrow, Paul T. Heath & Claire-Anne Siegrist. (2012) Use of pneumococcal polysaccharide vaccine in children. Current Opinion in Infectious Diseases 25:3, pages 292-303.
Crossref
Crossref
Christian Theilacker, Andrea Kropec, Felix Hammer, Irina Sava, Dominique Wobser, Tuerkan Sakinc, Jeroen D. C. Codée, Wouter F. J. Hogendorf, Gijsbert A. van der Marel & Johannes Huebner. (2012) Protection Against Staphylococcus aureus by Antibody to the Polyglycerolphosphate Backbone of Heterologous Lipoteichoic Acid. The Journal of Infectious Diseases 205:7, pages 1076-1085.
Crossref
Crossref
Siggeir F. Brynjolfsson, Maren Henneken, Stefania P. Bjarnarson, Elena Mori, Giuseppe Del Giudice & Ingileif Jonsdottir. (2012) Hyporesponsiveness Following Booster Immunization With Bacterial Polysaccharides Is Caused by Apoptosis of Memory B Cells. The Journal of Infectious Diseases 205:3, pages 422-430.
Crossref
Crossref
So Jung An, Yeon Kyung Yoon, Sudeep Kothari, Deok Ryun Kim, Jeong Ah Kim, Neha Kothari, Eugene Lee, Tai Hyun Park & Rodney Carbis. (2012) Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine. Vaccine 30:6, pages 1023-1028.
Crossref
Crossref
Thomas M. File, Michael D. Hogue, Kristin L. Nichol & William Schaffner. (2012) Update on Preventing Pneumococcal Disease in Adults. Infectious Diseases in Clinical Practice 20:1, pages 3-9.
Crossref
Crossref
Brian A. Kendall, Kristin K. Dascomb, Rajesh R. Mehta, Edward O. Mason, Krow Ampofo, David J. Pombo, Andrew T. Pavia & Carrie L. Byington. (2011) Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine 29:49, pages 9123-9126.
Crossref
Crossref